Stanislav Voháňka

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Poststroke delirium incidence and outcomes

Adéla Mitášová, Milena Košťálová, Josef Bednařík et al. · Critical Care Medicine · 2011 · 165 citations

Presymptomatic spondylotic cervical myelopathy: an updated predictive model

Josef Bednařík, Zdeněk Kadaňka, Ladislav Dušek et al. · European Spine Journal · 2008 · 162 citations · Full text

Lumbosacral Radiculopathy, Spinal Cord Injury, Updated Predictive Model +6

Conservative treatment versus surgery in spondylotic cervical myelopathy: a prospective randomised study

Zdeněk Kadaňka, Josef Bednařík, Stanislav Voháňka et al. · European Spine Journal · 2000 · 147 citations · Full text

Spinal Cord Injury, Spondyloarthritis, Spondylotic Cervical Myelopathy +6